Claims
- 1. A process for the preparation of surface-modified beads useful in isolation of biological material, said process comprising:
- a) contacting beads comprising polyacrylonitrile, or a copolymer of acrylonitrile and at least one comonomer, with an alkaline catalyst, a peroxide, and optionally a reducing agent under reaction conditions and for a time sufficient to convert at least a portion of the nitrile groups distributed on the surface of the substrate to amide groups;
- b) reacting said beads with a halogenating reagent under conditions and for a time sufficient to convert at least a portion of the amide groups to N-haloamide groups;
- c) reacting said beads with bioactive ligand selected from the group consisting of carboxylic acids, sulfonic acids, teritary amines, quaternary amines, peptides, hormones, enzyme cofactors, enzyme substrates, enzyme inhibitors, antigens, antibodies, dyes, pigments, complex metal ions, proteins, nucleic acids, p-aminobenzamides, polysaccharides, lectins, non-proteinaceous toxins, and antiotoxins, under conditions and for a time sufficient to effect the bonding of said ligand to said beads through said N-haloamide group; and d) recovering the resultant surface-modified beads.
- 2. The process of claim 1 wherein said substance comprises a copolymer of polyacrylonitrile wherein the polyacrylonitrile content of said substrate ranges from about 19 to 99 parts by weight.
- 3. The process of claim 2 wherein the polyacrylonitrile content of said substrate ranges from about 50 to about 98 parts by weight.
- 4. The process of claim 1 wherein said comonomer is selected from the group consisting of C.sub.2 -C.sub.6 mono-olefins, vinyl aminoaromatics, alkenyl aromatics, vinyl aromatics, vinyl halides, C.sub.2 -C.sub.6 alkyl(meth)acrylates, acrylamides, methacrylamides, vinyl pyrrolidones, vinyl pyridine, C.sub.1 -C.sub.6 hydroxesters of alkyl(meth)acrylates, meth(acrylic)acids, acrylomethylpropylsulfonic acids, N-hydroxy-containing C.sub.1 -C.sub.6 alky(meth)acrylamide, acrylamidomethylpropylsulfonic acids vinyl acetate, glycidyl (meth)acrylate, glycerol (meth)acrylate, tris(hydroxymethyl)aminomethyl (meth)acrylamide and mixtures thereof.
- 5. The process of claim 1 wherein said substrate comprises a copolymer of acylonitrile and methyl acrylate wherein said acrylonitrile comprises at least 90 mole percent of said substrate.
- 6. The process of claim 1 wherein said N-haloamide groups are selected from the group consisting of N-chloroamide, N-iodoamide and N-bromoamide groups.
- 7. The process of claim 1 wherein said N-haloamide groups comprise N-chloroamide groups.
- 8. The process of claim 1 wherein said bond of said bioligand and said substrate further comprises a bridging group.
- 9. The process of claim 8 wherein said bridging group is selected from the group consisting of C.sub.1 to C.sub.15 aliphatic, aromatic, cycloaliphatic groups which optionally contain heteroatoms, such as O, N or S.
- 10. The process of claim 1 wherein said bridging group is selected from the group consisting of ethylene glycol, diethylene glycol, triethylene glycol, glycerol, ethylenediamine, diethylenetriamine, ethanolamine, diethanolamine, 3,3'-diamino-N-methylpropylamine, hexanediamine, glycine, beta-alanine, tris(hydroxymethyl)aminoethane, 6-aminocaproic acid and polyoxyethylenediamine.
- 11. The product produced by the process of claim 1.
- 12. A composition of matter comprising:
- a porous bead comprising polyacrylonitrile or a copolymer of acrylonitrile and at least one comonomer, and
- b) a surface having evenly distributed thereon,
- i) pendant bioactive ligand groups selected from the group consisting of carboxylic acids, sulfonic acids, tertiary amines, quaternary amines, peptides, hormones, enzyme cofactors, enzyme substrates, enzyme inhibitors, antigens, antibodies, dyes, pigments, complex metal ions, proteins, nucleic acids, p-aminobenzamides, polysaccharides, lectins, non-proteinaceous toxins, and antiotoxins said bioactive ligand groups being bound to said surface through linkages derived from the reaction of bioactive ligands and N-haloamide groups bound to said surface, and, optionally
- ii) nitrile and/or amide groups.
- 13. The composition of claim 12 said bead comprises a copolymer of polyacrylonitrile wherein the polyacrylonitrile content of said substrate ranges from about 29 to 99 parts by weight.
- 14. The composition of claim 13 wherein the polyacrylonitrile content of said substrate ranges from about 50 to about 98 parts by weight.
- 15. The composition of claim 12 wherein said comonomer is selected from the group consisting of C.sub.2 -C.sub.6 mono-olefins, vinyl aminoaromatics, alkenyl aromatics, vinyl aromatics, vinyl halides, C.sub.2 -C.sub.6 alkyl(meth)acrylates, acrylamides, methacrylamides, vinyl pyrrolidones, vinyl pyridine, C.sub.1 -C.sub.6 hydroxesters of alkyl(meth)acrylates, meth(acrylic)acids, acrylomethylpropylsulfonic acids, N-hydroxy-containing C.sub.1 -C.sub.6 alky(meth)acrylamide, acrylamidomethylpropylsulfonic acids vinyl acetate, glycidyl (meth)acrylate, glycerol (meth)acrylate, tris(hydroxymethyl)aminomethyl (meth)acrylamide and mixtures thereof.
- 16. The composition of claim 12 wherein said bead comprises a copolymer of acrylonitrile and methyl acrylate wherein said acrylonitrile comprises at least 90 mole percent of said copolymer.
- 17. The composition of claim 12 wherein said N-haloamide groups are selected from the group consisting of N-chloroamide, N-iodoamide and N-bromoamide groups.
- 18. The composition of claim 12 wherein said N-haloamide groups comprise N-chloroamide and N-bromoamide groups.
- 19. The composition of claim 12 wherein said bond of said bioligand and said substrate further comprises a bridging group.
- 20. The composition of claim 19 wherein said bridging group is selected from the group consisting of C.sub.1 to C.sub.15 aliphatic, aromatic, cycloaliphatic groups which optionally contain heteroatoms, such as O, N or S.
- 21. The process of claim 12 wherein said bridging group is selected from the group consisting of ethylene glycol, diethylene glycol, triethylene glycol, glycerol, ethylenediamine, diethylenetriamine, ethanolamine, diethanolamine, 3,3'-diamino-N-methylpropylamine, hexanediamine, glycine, beta-alanine, tris(hydroxymethyl)aminomethane, 6-aminocaproic acid and polyoxyethylenediamine.
Parent Case Info
This is a divisional of co-pending application, Ser. No. 07/551,597, filed Jul. 11, 1992, U.S. Pat. No. 5,137,982 which in turn, is a continuation-in-part Ser. No. 07/348,448, filed May 8, 1989, now abandoned which is a continuation-in-part of Ser. No. 07/349,569 filed May 18, 1989, now abandoned.
US Referenced Citations (6)
Divisions (1)
|
Number |
Date |
Country |
Parent |
551597 |
Jul 1992 |
|
Continuation in Parts (2)
|
Number |
Date |
Country |
Parent |
348448 |
May 1989 |
|
Parent |
349569 |
May 1989 |
|